APO Research

APO RESEARCH · REPORT

One-Stop Radiotherapy

Selected research

Market Outlook & Growth Opportunities

Global One-Stop Radiotherapy Market Outlook and Growth Opportunities 2026

Market perspective

The global One-Stop Radiotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for One-Stop Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for One-Stop Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for One-Stop Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the One-Stop Radiotherapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the One-Stop Radiotherapy market include Dunlee, Varian Medical, Siemens Healthcare, Elekta, Ion Beam Applications, GE Healthcare, Shanghai United Imaging Intelligence and Shanghai Datu Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global One-Stop Radiotherapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of One-Stop Radiotherapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents One-Stop Radiotherapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global One-Stop Radiotherapy market.

One-Stop Radiotherapy Segment by Company

Dunlee

Varian Medical

Siemens Healthcare

Elekta

Ion Beam Applications

GE Healthcare

Shanghai United Imaging Intelligence

Shanghai Datu Medical Technology

One-Stop Radiotherapy Segment by Type

Stereotactic Radiosurgery

Stereotactic Body Radiotherapy

Others

One-Stop Radiotherapy Segment by Application

Rectal Cancer

Nasopharyngeal Carcinoma

Bladder Cancer

Lung Cancer

Others

One-Stop Radiotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global One-Stop Radiotherapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the One-Stop Radiotherapy key companies, revenue, market share, and recent developments.

3. To split the One-Stop Radiotherapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions One-Stop Radiotherapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify One-Stop Radiotherapy significant trends, drivers, influence factors in global and regions.

6. To analyze One-Stop Radiotherapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of One-Stop Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Radiotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global One-Stop Radiotherapy industry.

Chapter 3: Detailed analysis of One-Stop Radiotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of One-Stop Radiotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of One-Stop Radiotherapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. One-Stop Radiotherapy Industry Trends Table 2. One-Stop Radiotherapy Industry Drivers Table 3. One-Stop Radiotherapy Industry Opportunities and Challenges Table 4. One-Stop Radiotherapy Industry Restraints Table 5. Global One-Stop Radiotherapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global One-Stop Radiotherapy Revenue Share by Company (2021-2026) Table 7. Global One-Stop Radiotherapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global One-Stop Radiotherapy Key Company Manufacturing Base & Headquarters Table 9. Global One-Stop Radiotherapy Company, Product Type & Application Table 10. Global One-Stop Radiotherapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global One-Stop Radiotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stereotactic Radiosurgery Table 15. Significant Companies of Stereotactic Body Radiotherapy Table 16. Significant Companies of Others Table 17. Global One-Stop Radiotherapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global One-Stop Radiotherapy Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global One-Stop Radiotherapy Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global One-Stop Radiotherapy Sales Value Share by Type (2021-2026) Table 21. Global One-Stop Radiotherapy Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Rectal Cancer Table 23. Significant Companies of Nasopharyngeal Carcinoma Table 24. Significant Companies of Bladder Cancer Table 25. Significant Companies of Lung Cancer Table 26. Significant Companies of Others Table 27. Global One-Stop Radiotherapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global One-Stop Radiotherapy Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global One-Stop Radiotherapy Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global One-Stop Radiotherapy Sales Value Share by Application (2021-2026) Table 31. Global One-Stop Radiotherapy Sales Value Share by Application (2027-2032) Table 32. Global One-Stop Radiotherapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global One-Stop Radiotherapy Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global One-Stop Radiotherapy Sales Value Share by Region (2021-2026) Table 35. Global One-Stop Radiotherapy Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global One-Stop Radiotherapy Sales Value Share by Region (2027-2032) Table 37. Global One-Stop Radiotherapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global One-Stop Radiotherapy Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global One-Stop Radiotherapy Sales Value Market Share by Country (2021-2026) Table 40. Global One-Stop Radiotherapy Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global One-Stop Radiotherapy Sales Value Market Share by Country (2027-2032) Table 42. Dunlee Company Information Table 43. Dunlee Business Overview Table 44. Dunlee One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Dunlee One-Stop Radiotherapy Product Portfolio Table 46. Dunlee Recent Development Table 47. Varian Medical Company Information Table 48. Varian Medical Business Overview Table 49. Varian Medical One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Varian Medical One-Stop Radiotherapy Product Portfolio Table 51. Varian Medical Recent Development Table 52. Siemens Healthcare Company Information Table 53. Siemens Healthcare Business Overview Table 54. Siemens Healthcare One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Siemens Healthcare One-Stop Radiotherapy Product Portfolio Table 56. Siemens Healthcare Recent Development Table 57. Elekta Company Information Table 58. Elekta Business Overview Table 59. Elekta One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Elekta One-Stop Radiotherapy Product Portfolio Table 61. Elekta Recent Development Table 62. Ion Beam Applications Company Information Table 63. Ion Beam Applications Business Overview Table 64. Ion Beam Applications One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Ion Beam Applications One-Stop Radiotherapy Product Portfolio Table 66. Ion Beam Applications Recent Development Table 67. GE Healthcare Company Information Table 68. GE Healthcare Business Overview Table 69. GE Healthcare One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GE Healthcare One-Stop Radiotherapy Product Portfolio Table 71. GE Healthcare Recent Development Table 72. Shanghai United Imaging Intelligence Company Information Table 73. Shanghai United Imaging Intelligence Business Overview Table 74. Shanghai United Imaging Intelligence One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shanghai United Imaging Intelligence One-Stop Radiotherapy Product Portfolio Table 76. Shanghai United Imaging Intelligence Recent Development Table 77. Shanghai Datu Medical Technology Company Information Table 78. Shanghai Datu Medical Technology Business Overview Table 79. Shanghai Datu Medical Technology One-Stop Radiotherapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Shanghai Datu Medical Technology One-Stop Radiotherapy Product Portfolio Table 81. Shanghai Datu Medical Technology Recent Development Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. One-Stop Radiotherapy Product Image Figure 2. Global One-Stop Radiotherapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global One-Stop Radiotherapy Market Size (2021-2032) & (US$ Million) Figure 4. Global One-Stop Radiotherapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stereotactic Radiosurgery Image Figure 8. Stereotactic Body Radiotherapy Image Figure 9. Others Image Figure 10. Global One-Stop Radiotherapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global One-Stop Radiotherapy Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global One-Stop Radiotherapy Sales Value Share by Type (2021-2032) Figure 13. Rectal Cancer Image Figure 14. Nasopharyngeal Carcinoma Image Figure 15. Bladder Cancer Image Figure 16. Lung Cancer Image Figure 17. Others Image Figure 18. Global One-Stop Radiotherapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global One-Stop Radiotherapy Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global One-Stop Radiotherapy Sales Value Share by Application (2021-2032) Figure 21. Global One-Stop Radiotherapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global One-Stop Radiotherapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America One-Stop Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 24. North America One-Stop Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe One-Stop Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 26. Europe One-Stop Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific One-Stop Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific One-Stop Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America One-Stop Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 30. South America One-Stop Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa One-Stop Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa One-Stop Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt One-Stop Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiotherapy
  • Others
Applications
  • Rectal Cancer
  • Nasopharyngeal Carcinoma
  • Bladder Cancer
  • Lung Cancer
  • Others
Companies covered
  • Dunlee
  • Varian Medical
  • Siemens Healthcare
  • Elekta
  • Ion Beam Applications
  • GE Healthcare
  • Shanghai United Imaging Intelligence
  • Shanghai Datu Medical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global One-Stop Radiotherapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global One-Stop Radiotherapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 One-Stop Radiotherapy Market Dynamics
  1. 2.1 One-Stop Radiotherapy Industry Trends
  2. 2.2 One-Stop Radiotherapy Industry Drivers
  3. 2.3 One-Stop Radiotherapy Industry Opportunities and Challenges
  4. 2.4 One-Stop Radiotherapy Industry Restraints
3 One-Stop Radiotherapy Market by Company
  1. 3.1 Global One-Stop Radiotherapy Company Revenue Ranking in 2025
  2. 3.2 Global One-Stop Radiotherapy Revenue by Company (2021-2026)
  3. 3.3 Global One-Stop Radiotherapy Company Ranking (2024-2026)
  4. 3.4 Global One-Stop Radiotherapy Company Manufacturing Base and Headquarters
  5. 3.5 Global One-Stop Radiotherapy Company Product Type and Application
  6. 3.6 Global One-Stop Radiotherapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global One-Stop Radiotherapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 One-Stop Radiotherapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 One-Stop Radiotherapy Market by Type
  1. 4.1 One-Stop Radiotherapy Type Introduction
  2. 4.1.1 Stereotactic Radiosurgery
  3. 4.1.2 Stereotactic Body Radiotherapy
  4. 4.1.3 Others
  5. 4.2 Global One-Stop Radiotherapy Sales Value by Type
  6. 4.2.1 Global One-Stop Radiotherapy Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global One-Stop Radiotherapy Sales Value by Type (2021-2032)
  8. 4.2.3 Global One-Stop Radiotherapy Sales Value Share by Type (2021-2032)
5 One-Stop Radiotherapy Market by Application
  1. 5.1 One-Stop Radiotherapy Application Introduction
  2. 5.1.1 Rectal Cancer
  3. 5.1.2 Nasopharyngeal Carcinoma
  4. 5.1.3 Bladder Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global One-Stop Radiotherapy Sales Value by Application
  8. 5.2.1 Global One-Stop Radiotherapy Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global One-Stop Radiotherapy Sales Value by Application (2021-2032)
  10. 5.2.3 Global One-Stop Radiotherapy Sales Value Share by Application (2021-2032)
6 One-Stop Radiotherapy Regional Value Analysis
  1. 6.1 Global One-Stop Radiotherapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global One-Stop Radiotherapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global One-Stop Radiotherapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global One-Stop Radiotherapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America One-Stop Radiotherapy Sales Value (2021-2032)
  7. 6.3.2 North America One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe One-Stop Radiotherapy Sales Value (2021-2032)
  10. 6.4.2 Europe One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific One-Stop Radiotherapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America One-Stop Radiotherapy Sales Value (2021-2032)
  16. 6.6.2 South America One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa One-Stop Radiotherapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
7 One-Stop Radiotherapy Country-level Value Analysis
  1. 7.1 Global One-Stop Radiotherapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global One-Stop Radiotherapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global One-Stop Radiotherapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global One-Stop Radiotherapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Dunlee
  2. 8.1.1 Dunlee Company Information
  3. 8.1.2 Dunlee Business Overview
  4. 8.1.3 Dunlee One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Dunlee One-Stop Radiotherapy Product Portfolio
  6. 8.1.5 Dunlee Recent Developments
  7. 8.2 Varian Medical
  8. 8.2.1 Varian Medical Company Information
  9. 8.2.2 Varian Medical Business Overview
  10. 8.2.3 Varian Medical One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Varian Medical One-Stop Radiotherapy Product Portfolio
  12. 8.2.5 Varian Medical Recent Developments
  13. 8.3 Siemens Healthcare
  14. 8.3.1 Siemens Healthcare Company Information
  15. 8.3.2 Siemens Healthcare Business Overview
  16. 8.3.3 Siemens Healthcare One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Siemens Healthcare One-Stop Radiotherapy Product Portfolio
  18. 8.3.5 Siemens Healthcare Recent Developments
  19. 8.4 Elekta
  20. 8.4.1 Elekta Company Information
  21. 8.4.2 Elekta Business Overview
  22. 8.4.3 Elekta One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elekta One-Stop Radiotherapy Product Portfolio
  24. 8.4.5 Elekta Recent Developments
  25. 8.5 Ion Beam Applications
  26. 8.5.1 Ion Beam Applications Company Information
  27. 8.5.2 Ion Beam Applications Business Overview
  28. 8.5.3 Ion Beam Applications One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ion Beam Applications One-Stop Radiotherapy Product Portfolio
  30. 8.5.5 Ion Beam Applications Recent Developments
  31. 8.6 GE Healthcare
  32. 8.6.1 GE Healthcare Company Information
  33. 8.6.2 GE Healthcare Business Overview
  34. 8.6.3 GE Healthcare One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GE Healthcare One-Stop Radiotherapy Product Portfolio
  36. 8.6.5 GE Healthcare Recent Developments
  37. 8.7 Shanghai United Imaging Intelligence
  38. 8.7.1 Shanghai United Imaging Intelligence Company Information
  39. 8.7.2 Shanghai United Imaging Intelligence Business Overview
  40. 8.7.3 Shanghai United Imaging Intelligence One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai United Imaging Intelligence One-Stop Radiotherapy Product Portfolio
  42. 8.7.5 Shanghai United Imaging Intelligence Recent Developments
  43. 8.8 Shanghai Datu Medical Technology
  44. 8.8.1 Shanghai Datu Medical Technology Company Information
  45. 8.8.2 Shanghai Datu Medical Technology Business Overview
  46. 8.8.3 Shanghai Datu Medical Technology One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Datu Medical Technology One-Stop Radiotherapy Product Portfolio
  48. 8.8.5 Shanghai Datu Medical Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research